Last reviewed · How we verify

Zushima plaster with high dose

Guang'anmen Hospital of China Academy of Chinese Medical Sciences · FDA-approved active Small molecule

Zushima plaster is a traditional Chinese medicine transdermal patch formulation designed to provide pain relief and anti-inflammatory effects through topical delivery of herbal active compounds.

Zushima plaster is a traditional Chinese medicine transdermal patch formulation designed to provide pain relief and anti-inflammatory effects through topical delivery of herbal active compounds. Used for Localized pain and inflammation (specific indications not fully documented in available sources).

At a glance

Generic nameZushima plaster with high dose
SponsorGuang'anmen Hospital of China Academy of Chinese Medical Sciences
ModalitySmall molecule
Therapeutic areaPain Management / Musculoskeletal Disorders
PhaseFDA-approved

Mechanism of action

As a high-dose plaster formulation, Zushima delivers concentrated herbal ingredients through the skin to target localized pain and inflammation. The specific active constituents and their molecular mechanisms are characteristic of traditional Chinese medicine preparations, which typically work through multiple pathways including anti-inflammatory, analgesic, and circulation-promoting effects. The transdermal delivery system allows sustained release of therapeutic compounds to affected areas.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: